Tag Archives: #COVID19

After a Vaccine – What? The Shift from Research and Discovery to Communications

Vaccines for COVID-19 are the focus of the moment – politically and scientifically speaking. On the political front, there has not only been jockeying to try to squeeze the square peg of a vaccine development timeline into a round hole … Continue reading

Posted in Uncategorized | Tagged | Comments Off on After a Vaccine – What? The Shift from Research and Discovery to Communications

Webinar on the Medical and Legal Aspects of COVID-19

Any pandemic is a medical crisis first, but it is also a social crisis and in the case of COVID-19, it has been a financial crisis. On top of that, emerging pathogens push new legal issues into the forefront. Currently … Continue reading

Posted in About Me, Current Affairs | Tagged , | Comments Off on Webinar on the Medical and Legal Aspects of COVID-19

The OK for Patients’ Return to Healthcare Needs Clear Signals From Trusted Sources

COVID-19 was a shock to the system unlike anything that had been anticipated. Even prior to the shutdown, health-perceptive people were starting to avoid public venues and there were declines in the numbers of people going out to eat at … Continue reading

Posted in COVID19, Current Affairs | Tagged , | Comments Off on The OK for Patients’ Return to Healthcare Needs Clear Signals From Trusted Sources

The Pharmaceutical-Biotech-Devices Industries Face a New World Post-Pandemic

There is going to be a time in the not too distant future, when the fuller picture of the healthcare impacts of COVID-19 come into sharper focus. When that happens, it is not likely to be pretty. In large part, … Continue reading

Posted in COVID19, Current Affairs, Pharma Industry Image | Tagged , , | Comments Off on The Pharmaceutical-Biotech-Devices Industries Face a New World Post-Pandemic

Impact of COVID-19 on FDA Enforcement and Approvals – Part 5 – FDA Provides Update to Shape Expectations on New Approvals

In response to written questions submitted last month regarding the potential for delays, FDA had stated that “CDER remains fully capable to continue daily activities, while responding to the public needs of the current COVID-19 outbreak.” In a subsequent blog … Continue reading

Posted in Approval Announcements, COVID19, FDA Policy | Tagged , | 1 Comment